Top 2020 meeting news: Dapagliflozin trial data, post-obesity weight maintenance and more
Health care conferences around the world looked completely different in 2020 as the COVID-19 pandemic forced organizations to conduct virtual meetings.
Even with the format changes, plenty of important findings were discussed in 2020. Healio readers were interested in dapagliflozin’s role in reducing new-onset diabetes in adults with heart failure, the possibility that drinking more water can boost cognition in children, and the use of cannabis for treating menopause symptoms.
Here are some of Healio’s most-read stories from endocrinology meetings in 2020.
DAPA-HF: Dapagliflozin reduces new-onset diabetes among adults with heart failure
Adults with heart failure assigned the SGLT2 inhibitor dapagliflozin had a 32% lower risk for new-onset type 2 diabetes over 18 months of follow-up vs. placebo, according to trial data presented at the virtual American Diabetes Association Scientific Sessions.
Circadian rhythm disruption may accelerate aging, drive cardiometabolic disease
Circadian rhythm disruptions from light exposure, dietary challenges and timing of food intake can be a driver for cardiometabolic disease, according to a presenter at the virtual American Society for Bone and Mineral Research Annual Meeting.
Increased water intake may boost cognition among children
According to a presenter at the European and International Congress on Obesity virtual meeting, water intake among children falls far below European guideline recommendations and drinking more water may improve cognition.
Old genetic discoveries may reveal ‘new tricks’ for treating obesity
Genetic modifiers could be used to better understand the processes and mechanisms behind weight gain and one day even regulate appetite, according to a speaker at ObesityWeek Interactive.
Cannabis use ‘common’ approach to treating menopause symptoms
In a cohort of midlife women who received care through the Department of Veterans Affairs in Northern California, more than one-fourth reported using cannabis to treat menopause symptoms, according to a presenter at the North American Menopause Society virtual meeting.
Physical activity volume, motivation key to maintaining weight loss post-obesity
Providers should focus on physical activity volume and motivate individuals with obesity to maintain weight loss, according to a speaker at the virtual Cardiometabolic Health Congress.
World’s first drone delivery of insulin may be useful model in pandemic response
The use of drones for health care delivery may be useful during a future pandemic after a drone was used to deliver insulin to a person with diabetes in a remote location in Ireland early in 2020, according to a speaker at the Endocrine Society Annual Meeting.
Safe intermittent fasting possible for people with diabetes
People with well-managed diabetes can safely try intermittent fasting as long as they pay careful attention to glucose levels with continuous glucose monitoring, according to two speakers at the Association of Diabetes Care and Education Specialists virtual meeting.
Proactive measures can reduce COVID-19 severity risk in obesity
With obesity and elevated BMI both identified as risk factors for adverse COVID-19 outcomes, a speaker at the virtual Heart in Diabetes conference said providers must work with patients to appropriately control these risk factors.
Once-weekly insulin efficacy similar to daily therapy in type 2 diabetes
Adults with type 2 diabetes who received an investigational once-weekly insulin therapy had a decrease in HbA1c similar to that seen with daily insulin glargine, according to randomized controlled trial data presented at the European Association for the Study of Diabetes virtual meeting.
Probiotic supplement may boost weight loss for children with obesity
Children with obesity receiving a probiotic supplement with two strains of bifidobacteria had increased insulin sensitivity and reductions in BMI, according to a speaker at the European Congress of Endocrinology virtual meeting.